Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L POOL

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
British Journal of Urology|November 14, 1997
Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and futureR S Kirby, J L Pool
Neurosurgery|June 1, 1996
A history of the Neurological Institute of New York and its Department of Neurological SurgeryD O Quest, J L Pool
Prostate Cancer and Prostatic Diseases|December 24, 2002
Interpretation of the ALLHAT interim analysis and implications for the treatment of patients with BPHR S Kirby, J L Pool
International Urology and Nephrology|September 17, 2002
Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasiaJ L Pool, R S Kirby
The Journal of Urology|February 1, 1988
Isolated renal artery dissection secondary to medial degenerationR Goldfarb, J L Pool, T Wheeler
Journal of Human Hypertension|October 1, 1990
Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterationsJ L Pool, M L Lenz, A A Taylor
Clinical Pharmacology and Therapeutics|December 1, 1986
Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonistE B Nelson, J L Pool, A A Taylor
The American Journal of Medicine|September 23, 1988
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patientsJ L Pool, E B Nelson, A A Taylor
The American Journal of Medicine|October 31, 1986
Pharmacology of angiotensin converting enzyme inhibitors. A reviewE B Nelson, J L Pool, A A Taylor
The American Journal of Medicine|August 16, 1989
Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertensionJ L Pool, A A Taylor, E B Nelson
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Urology|November 14, 1997
Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and futureR S Kirby, J L Pool
Neurosurgery|June 1, 1996
A history of the Neurological Institute of New York and its Department of Neurological SurgeryD O Quest, J L Pool
Prostate Cancer and Prostatic Diseases|December 24, 2002
Interpretation of the ALLHAT interim analysis and implications for the treatment of patients with BPHR S Kirby, J L Pool
International Urology and Nephrology|September 17, 2002
Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasiaJ L Pool, R S Kirby
The Journal of Urology|February 1, 1988
Isolated renal artery dissection secondary to medial degenerationR Goldfarb, J L Pool, T Wheeler
Journal of Human Hypertension|October 1, 1990
Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterationsJ L Pool, M L Lenz, A A Taylor
Clinical Pharmacology and Therapeutics|December 1, 1986
Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonistE B Nelson, J L Pool, A A Taylor
The American Journal of Medicine|September 23, 1988
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patientsJ L Pool, E B Nelson, A A Taylor
The American Journal of Medicine|October 31, 1986
Pharmacology of angiotensin converting enzyme inhibitors. A reviewE B Nelson, J L Pool, A A Taylor
The American Journal of Medicine|August 16, 1989
Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertensionJ L Pool, A A Taylor, E B Nelson
Pageof 5